Epilepsy in Patients With Primary CNS Lymphoma
Dr. Kait Nevel and Dr. Oumaima Aboubakr discuss the prevalence of epilepsy in primary CNS lymphoma. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209748

Dr. Kait Nevel and Dr. Oumaima Aboubakr discuss the prevalence of epilepsy in primary CNS lymphoma. Show reference: https://www.neurology.org/doi/abs/10.1212/WNL.0000000000209748
In the final part of this three-part series, Drs. Stacey Clardy, Elisabeth Bik, and Matthew Schrag discuss how to uphold research integrity. Show reference: https://undark.org/2024/09/11/the-rise-of-the-science-sleuths/
Dr. Stacey Clardy discusses why B vitamins matter in neurology in this lab minute.
Dr. Stacey Clardy discusses what to check instead of ACE levels if you suspect a diagnosis of sarcoidosis in this lab minute.
Dr. Rae Bacharach talks with Dr. Manon Auffret about her NeuroByte titled, "How to Respond to a Request for Hastened Death from a Person Living with Neurologic Illness". Show reference: https://learning.aan.com/courses/74069
In part two of this series, Drs. Stacey Clardy, Elisabeth Bik, and Matthew Schrag discuss the best ways that we as neurology clinicians and researchers can help to actively prevent fraud. Show references: https://undark.org/2024/09/11/the-rise-of-the-science-sleuths/
In the first part of this special three-part series, Drs. Stacey Clardy, Elisabeth Bik, and Matthew Schrag discuss critical issues surrounding research integrity and misconduct. Show references: https://undark.org/2024/09/11/the-rise-of-the-science-sleuths/
Dr. Stacey Clardy discusses the four different testable thyroid antibodies. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000008785 https://academic.oup.com/braincomms/article/3/2/fcaa233/6064134
Dr. Stacey Clardy discusses how to test for IgG4-related disease and how to interpret MIR imaging findings. Show reference: https://ard.bmj.com/content/74/1/14a
Drs. Jeff Ratliff, Nanditha Rajamani, and Andy Horn discuss the potential for wider use of algorithmic or computational approaches to guide clinical DBS programming in the clinic and the remaining hurdles. Show reference: https://www.nature.com/articles/s41467-024-48731-1
Dr. Farrah Mateen and Dr. Katrin Seeher discuss the significant global burden of neurologic conditions, which affects over 3.4 billion people worldwide, and the strategies the WHO is implementing to improve care and awareness. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00038-3/fulltext#seccestitle10
Drs. Jeff Ratliff, Nanditha Rajamani, and Andy Horn discuss what this study taught us about the use of deep brain stimulation when taking into account certain white matter tracts associated with key clinical Parkinson motor symptoms. Show reference: https://www.nature.com/articles/s41467-024-48731-1
Dr. Stacey Clardy discusses the importance of iron and ferritin in neurology in this lab minute.
Dr. Rae Bacharach discusses the Neurology Today article, "What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy" by Gina Shaw, available in the September 19th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09190/what_neurologists_should_know_about.2.aspx#:~:text=Neurologists%20frequently%20prescribe%20antidepressants%20for%20managing%20neuropathy%20and,likely%20to%20become%20nonadherent%20to%20co...
In the final part of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the management of epilepsy in transgender or gender diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
Dr. Shuvro Roy and Dr. Anne Louise Oaklander discuss the big-picture takeaways for clinicians in the context of managing small-fiber neuropathy. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200286
Dr. Dara Albert and Dr. Jaclyn M. Martindale discuss the differences in gender representation among leadership positions and award recipients within the Child Neurology Society. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209746
In part two of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss cerebrovascular risk and management in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
In part one of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the crucial aspects about managing headaches in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332
In part two of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss essential advice for general neurologists who suspect a patient might have an atypical disorder. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345
Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496
Dr. Irfan Sheikh explores a newly released NeuroByte episode, providing an insightful overview of how AI technologies, including ambient intelligence, can streamline documentation processes and enhance the efficiency of clinical practices. Show references: https://learning.aan.com/courses/74256
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577
Dr. Rae Bacharach discusses the Neurology Today article, "Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene?" by Gina Shaw, available in the September 5th issue of Neurology Today or at neurologytoday.com . Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09050/large_study_finds_covid_vaccination_does_not.3.aspx...
In the first installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina explore the biology of PACAP, its significance in relation to migraines, and its potential as a novel therapeutic approach. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577
Dr. Amy Gelfand and Dr. Matthew Bender discuss the possible association between glymphatic outflow and extent of TSS in patients with IIH. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209529
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org . Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209745...
Dr. Rae Bacharach discusses the Neurology Today article, "Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses" by Susan FitzGerald, available in the September 5th issue of Neurology Today or at neurologytoday.com . Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09050/large_study_finds_covid_vaccination_does_not.3.aspx...
In the third episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the critical objective of advancing the quality of life for individuals with SMA in the coming years. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310
Dr. David Perez and Dr. Glenn Nielsen discuss the effectiveness of physiotherapy in treating functional motor disorder and to determine the best approach for physiotherapy treatment. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00135-2/fulltext